Smart Brothers SMART SLEEP

Product guide · Restricted substance

Smart Brothers SMART SLEEP

Smart Brothers

Product with a restricted ingredient from Smart Brothers. This guide sets out what the manufacturer states about the composition of Smart Brothers SMART SLEEP, what independent research says about its main ingredients, and the safety and regulatory points that apply. It contains substances that are not authorised as food or medicine in the EU. This guide is educational: it does not recommend use and gives no directions for use.

Educational guide · Sources checked 4 November 2026 · 11 references

Back to the product
Named ingredients
5
Amounts stated
None
Status
Restricted substance
Evidence summaries
5

Overview

Manufacturer information

Ingredients & composition

Manufacturer information
IngredientAmount
PhenibutNot stated
MelatoninNot stated
Valerian rootNot stated
5-HTPNot stated
Mucuna pruriensNot stated

The manufacturer does not state the amount of any ingredient. Without amounts, the research summarised in this guide cannot be related to this product's dose.

Scientific background

Independent research

Phenibut

Phenibut (β-phenyl-γ-aminobutyric acid) is a GABA-B receptor agonist, a central nervous system depressant used as a medicine in Russia1.

Melatonin

Melatonin is a hormone produced by the pineal gland at night that helps regulate the sleep–wake cycle.

Valerian root

Valerian (Valeriana officinalis) root is a traditional herbal remedy for sleep and nervousness.

5-HTP (5-hydroxytryptophan)

5-HTP is the direct precursor of the neurotransmitter serotonin and is usually extracted from Griffonia simplicifolia seeds2.

Mucuna pruriens (velvet bean, L-DOPA)

Mucuna pruriens seeds naturally contain L-DOPA (levodopa), the precursor of dopamine and the main medicine for Parkinson's disease.

Research evidence

Independent research

Phenibut

There are no controlled trials in healthy people supporting its use as a supplement.

Melatonin

The EU authorises the claim that melatonin contributes to the reduction of time taken to fall asleep, for products providing 1 mg close to bedtime, and a claim on the relief of jet lag at 0.5 mg34.

A meta-analysis found that melatonin modestly reduced the time taken to fall asleep and increased total sleep time in people with primary sleep disorders5.

Valerian root

An umbrella review found a good safety profile but no evidence of efficacy for treating insomnia; some subjective improvement in sleep quality was reported, not confirmed by objective measures6.

5-HTP (5-hydroxytryptophan)

A review of controlled trials examined 5-HTP for depression; the evidence is limited and of mixed quality2. There is no authorised EU claim for 5-HTP.

Mucuna pruriens (velvet bean, L-DOPA)

A 12-month randomised trial in untreated Parkinson's disease in sub-Saharan Africa found Mucuna pruriens could be a cost-effective alternative where commercial levodopa is not available7. There is no good evidence that it raises testosterone or improves mood or performance in healthy people.

Evidence limitations

Independent research

This product does not state all ingredient amounts, so the doses used in research cannot be compared with what one serving provides.

The studies summarised in this guide examined single ingredients. No published study has tested this product or this combination of ingredients.

Phenibut

Its marketing as a nootropic supplement is not supported by evidence1.

Melatonin

The effects are modest5. Higher doses have not been shown to work better for falling asleep.

Valerian root

High-quality randomised trials are scarce6.

5-HTP (5-hydroxytryptophan)

Most trials are small and old2.

Mucuna pruriens (velvet bean, L-DOPA)

The trial used standardised preparations under medical supervision; larger double-blind trials are needed7. Supplements rarely state their L-DOPA content.

Safety & potential risks

Independent research

Phenibut

A systematic review describes serious toxicity and withdrawal syndromes with phenibut, including agitation, delirium and reduced consciousness, often requiring hospital treatment8. Dependence can develop quickly.

Melatonin

Melatonin may cause daytime drowsiness and headache, and it can interact with sedatives, blood thinners and some antidepressants. Do not drive or operate machinery if drowsy.

Valerian root

Generally safe; it may cause drowsiness and should not be combined with sedatives or alcohol6.

5-HTP (5-hydroxytryptophan)

Safety concerns include serotonin syndrome when combined with antidepressants or other serotonergic substances, and historical reports of eosinophilia-myalgia syndrome linked to contaminated products2. Do not combine with antidepressants, migraine triptans or tramadol.

Mucuna pruriens (velvet bean, L-DOPA)

L-DOPA can cause nausea, low blood pressure, involuntary movements and psychiatric effects, and it interacts with MAO inhibitors, antipsychotics and Parkinson's medicines. People with heart disease, psychiatric conditions or melanoma history should not use it without medical advice.

Regulatory status

GIGACULT product information

Contains a synthetic research compound that is not authorised as food (novel food) or as a medicinal product in the EU. Contains melatonin. Products providing 1 mg or more of melatonin per daily dose are classified as medicinal products in several EU member states. No dosing information for human use is provided.

Regulation and sport

Phenibut

Phenibut is not authorised as a food or food supplement ingredient in the EU9. Substances with a pharmacological action on the nervous system are regulated as medicinal products in the EU, and Phenibut is not an authorised medicine10.

Melatonin

Melatonin is permitted in food supplements in some EU countries only up to set amounts; above those amounts, or in some Member States at any dose, it is regulated as a medicine10.

Valerian root

Some valerian preparations are traditional herbal medicines in the EU10. No health claim for this ingredient is authorised in the EU3; it is sold under national food-supplement rules11.

5-HTP (5-hydroxytryptophan)

5-HTP is pharmacologically active; some EU Member States restrict it in food supplements or classify it as medicinal10. No health claim for this ingredient is authorised in the EU3; botanical ingredients are sold under national food-supplement rules11.

Mucuna pruriens (velvet bean, L-DOPA)

Because it contains levodopa, a medicinal substance, the classification of Mucuna pruriens products differs between EU Member States10. No health claim for this ingredient is authorised in the EU3; botanical ingredients are sold under national food-supplement rules11.

Scientific references

  1. Gurley BJ, Koturbash I. Phenibut: a drug with one too many 'buts'. Basic Clin Pharmacol Toxicol. 2024;135:409-416. PubMed 39197876
  2. Turner EH, Loftis JM, Blackwell AD. Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan. Pharmacol Ther. 2006;109:325-338. PubMed 16023217
  3. Commission Regulation (EU) No 432/2012 establishing a list of permitted health claims made on foods. Official Journal of the European Union. Source
  4. EFSA NDA Panel. Scientific Opinion on the substantiation of a health claim related to melatonin and reduction of sleep onset latency. EFSA Journal. 2011;9:2241. DOI 10.2903/j.efsa.2011.2241
  5. Ferracioli-Oda E, Qawasmi A, Bloch MH. Meta-analysis: melatonin for the treatment of primary sleep disorders. PLoS One. 2013;8:e63773. PubMed 23691095
  6. Valente V, Machado D, Jorge S, et al. Does valerian work for insomnia? An umbrella review of the evidence. Eur Neuropsychopharmacol. 2024;82:6-28. PubMed 38359657
  7. Cilia R, Cham M, Obese V, et al. Mucuna pruriens in untreated Parkinson's disease in sub-Saharan Africa: a 12-month, multicenter, randomized, controlled trial. J Parkinsons Dis. 2026;16:99-109. PubMed 41269916
  8. Weleff J, Kovacevich A, Burson J, et al. Clinical presentations and treatment of phenibut toxicity and withdrawal: a systematic literature review. J Addict Med. 2023;17:407-417. PubMed 37579098
  9. Regulation (EU) 2015/2283 on novel foods. Official Journal of the European Union. Source
  10. Directive 2001/83/EC on the Community code relating to medicinal products for human use. Official Journal of the European Union. Source
  11. Directive 2002/46/EC on the approximation of the laws of the Member States relating to food supplements. Official Journal of the European Union. Source

Sources checked against PubMed, Crossref or the official publisher on 2026-11-04. Manufacturer information is taken from the product's own data and has not been independently tested.

The product

Smart Brothers SMART SLEEP

€44,90

View product